These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12771941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H, Sylvestre JR, Jolicoeur P.
    Oncogene; 2010 Aug 12; 29(32):4543-54. PubMed ID: 20562911
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.
    Cancer Res; 2007 Aug 01; 67(15):7212-22. PubMed ID: 17671189
    [Abstract] [Full Text] [Related]

  • 9. Regulatory function of whey acidic protein in the proliferation of mouse mammary epithelial cells in vivo and in vitro.
    Nukumi N, Ikeda K, Osawa M, Iwamori T, Naito K, Tojo H.
    Dev Biol; 2004 Oct 01; 274(1):31-44. PubMed ID: 15355786
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS.
    Am J Pathol; 2005 Aug 22; 167(2):585-97. PubMed ID: 16049342
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M, Lewis B, Capuco AV, Laucirica R, Furth PA.
    Oncogene; 2000 Feb 21; 19(8):1010-9. PubMed ID: 10713684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.
    Oncogene; 2000 Dec 07; 19(52):6007-14. PubMed ID: 11146552
    [Abstract] [Full Text] [Related]

  • 16. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 17. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
    Santarelli R, Tzeng YJ, Zimmermann C, Guhl E, Graessmann A.
    Oncogene; 1996 Feb 01; 12(3):495-505. PubMed ID: 8637705
    [Abstract] [Full Text] [Related]

  • 18. Understanding mammary gland development through the imbalanced expression of growth regulators.
    Robinson GW, Smith GH, Gallahan D, Zimmer A, Furth PA, Hennighausen L.
    Dev Dyn; 1996 Jun 01; 206(2):159-68. PubMed ID: 8725283
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.
    Li M, Hu J, Heermeier K, Hennighausen L, Furth PA.
    Cell Growth Differ; 1996 Jan 01; 7(1):13-20. PubMed ID: 8788029
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.
    Nat Cell Biol; 2007 May 01; 9(5):493-505. PubMed ID: 17450133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.